Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Current Vascular Pharmacology|June 3, 2009
ErbB targeted drugs and angiogenesisErika Iivanainen, Klaus EleniusRecent Patents on DNA & Gene Sequences|December 17, 2008
ErbB4 and its isoforms: patentable drug targets?Ilkka Paatero, Klaus EleniusFuture Oncology (London, England)|December 22, 2009
Potential of ErbB4 antibodies for cancer therapyMaija Hollmén, Klaus EleniusOncogene|September 1, 2018
Gamma-secretase-dependent signaling of receptor tyrosine kinasesJohannes A M Merilahti, Klaus EleniusMicroscopy Research and Technique|December 25, 2002
Endothelial cell-matrix interactionsErika Iivanainen, Veli-Matti Kähäri, Jyrki Heino, et al.The Journal of Biological Chemistry|June 29, 2004
Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1Varpu Elenius, Martin Götte, Ofer Reizes, et al.Scientific Reports|August 18, 2021
Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxiaJuho Heliste, Anne Jokilammi, Katri Vaparanta, et al.Plos One|September 20, 2019
Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulationMahlet Z Tamirat, Marika Koivu, Klaus Elenius, et al.Expert Opinion on Emerging Drugs|April 27, 2010
EGFR targeting drugs in the treatment of head and neck squamous cell carcinomaMaria Sundvall, Anna Karrila, Janne Nordberg, et al.Cancers|April 3, 2021
Structural Basis for the Functional Changes by EGFR Exon 20 Insertion MutationsMahlet Z Tamirat, Kari J Kurppa, Klaus Elenius, et al.Pageof 8